एपीआई एक विस्तृत बीमारी जानकारी प्रदान करता है, चिकित्सा विश्लेषण और अनुप्रयोगों के लिए प्रमुख डेटा तक पहुंच को सुविधाजनक बनाता है। विशेष संबंधित जीन से लेकर आनुवंशिक परिवर्तनों और संबंधित फेनोटाइप्स तक, यह एपीआई विभिन्न चिकित्सा स्थितियों को समझने और संबोधित करने के लिए एक अमूल्य उपकरण बन जाता है।
अपने मूल में, एपीआई व्यापक बीमारी डेटा तक पहुंच प्रदान करता है, जिससे ऐसे जानकारी का क्वेरीकरण संभव होता है जैसे किसी विशेष बीमारी से जुड़े जीन, स्थिति के साथ पहचाने गए आनुवंशिक परिवर्तन, और संबंधित नैदानिक फेनोटाइप्स। यह जानकारी शोधकर्ताओं के लिए आवश्यक है जो बीमारियों के आनुवंशिक आधार का अध्ययन कर रहे हैं, क्योंकि यह स्पष्ट जानकारी प्रदान करता है कि कैसे कुछ जीन और उनके परिवर्तन किसी विशेष बीमारी के प्रति प्रवृत्ति या विकास को प्रभावित कर सकते हैं।
एपीआई की एक विशेषता यह है कि यह स्वास्थ्य देखभाल और जैव चिकित्सा अनुसंधान में मौजूदा अनुप्रयोगों और प्रणालियों के साथ आसानी से एकीकृत होने की क्षमता रखता है। यह डेवलपर्स को अनुकूलित उपकरण बनाने की अनुमति देता है जो एपीआई डेटा का उपयोग करके जटिल बीमारियों के निदान, उपचार और समझ में सुधार करते हैं।
संक्षेप में, एपीआई न केवल बीमारियों, जीन और आनुवंशिक परिवर्तनों पर विस्तृत और सटीक डेटा तक पहुंच प्रदान करता है, बल्कि वैज्ञानिक अनुसंधान, चिकित्सा नवाचार और साक्ष्य आधारित स्वास्थ्य देखभाल के निरंतर सुधार का समर्थन करने की क्षमता के लिए भी अद्वितीय है। इसकी बहुपरकारिता और मजबूती किसी भी चिकित्सक या शोधकर्ता के लिए एक अनिवार्य उपकरण बनाती है जो उन्नत जीनोमिक और नैदानिक दृष्टिकोण से बीमारियों की जटिलताओं को समझने और संबोधित करने की कोशिश कर रहा है।
यह एक पैरामीटर प्राप्त करेगा और आपको एक JSON प्रदान करेगा।
एपीआई कॉल की संख्या के अलावा, कोई और सीमा नहीं है।
रोग - एंडपॉइंट फीचर्स
| ऑब्जेक्ट | विवरण |
|---|---|
q |
[आवश्यक] |
{"took":16,"total":724,"max_score":7.9725885,"hits":[{"_id":"MONDO:0011361","_score":7.9725885,"ctd":{"omim":"603688","pathway_related_to_disease":[{"inference_gene_symbol":"EPHB2","kegg_pathway_id":"hsa04360","pathway_name":"Axon guidance","source":"CTD"},{"inference_gene_symbol":"EPHB2","pathway_name":"Developmental Biology","react_pathway_id":"R-HSA-1266738","source":"CTD"},{"inference_gene_symbol":"EPHB2","pathway_name":"EPH-Ephrin signaling","react_pathway_id":"R-HSA-2682334","source":"CTD"},{"inference_gene_symbol":"EPHB2","pathway_name":"L1CAM interactions","react_pathway_id":"R-HSA-373760","source":"CTD"},{"inference_gene_symbol":"EPHB2","pathway_name":"EPHB-mediated forward signaling","react_pathway_id":"R-HSA-3928662","source":"CTD"},{"inference_gene_symbol":"EPHB2","pathway_name":"Ephrin signaling","react_pathway_id":"R-HSA-3928664","source":"CTD"},{"inference_gene_symbol":"EPHB2","pathway_name":"EPH-ephrin mediated repulsion of cells","react_pathway_id":"R-HSA-3928665","source":"CTD"},{"inference_gene_symbol":"EPHB2","pathway_name":"Axon guidance","react_pathway_id":"R-HSA-422475","source":"CTD"}]},"disgenet":{"_license":"https://creativecommons.org/licenses/by/4.0/","genes_related_to_disease":[{"DPI":0.846,"DSI":0.374,"gene_id":2048,"gene_name":"EPHB2","score":0.4,"source":"CLINVAR"},{"DPI":0.846,"DSI":0.374,"gene_id":2048,"gene_name":"EPHB2","score":0.4,"source":"CTD_human"}],"variants_related_to_disease":[{"DSI":1.0,"chrom":"1","pos":22907980,"rsid":"rs121912582","score":0.7,"source":"CLINVAR"},{"DPI":0.08,"DSI":0.882,"chrom":"1","pos":22913757,"rsid":"rs76826147","score":0.7,"source":"CLINVAR"}],"xrefs":{"disease_name":"PROSTATE CANCER/BRAIN CANCER SUSCEPTIBILITY (finding)","mondo":"MONDO:0011361","omim":"603688","umls":"C1863600"}},"hpo":{"disease_name":"Prostate cancer/brain cancer susceptibility","omim":"603688","phenotype_related_to_disease":[{"biocuration":{"date":"2013-01-14","name":"HPO:skoehler"},"evidence":"IEA","hpo_id":"HP:0100006","omim_refs":"OMIM:603688","original_disease_id":"OMIM:603688"},{"biocuration":{"date":"2013-01-09","name":"HPO:skoehler"},"evidence":"IEA","hpo_id":"HP:0012125","omim_refs":"OMIM:603688","original_disease_id":"OMIM:603688"}]},"mondo":{"ancestors":["MONDO:0003847","MONDO:0020573","MONDO:0023370","MONDO:0021058","MONDO:0700096","MONDO:0002254","MONDO:0045024","MONDO:0042489","MONDO:0015356","MONDO:0000001"],"excluded_subClassOf":{"mondo":["MONDO:0008315"]},"has_material_basis_in_germline_mutation_in":{"http":["http://identifiers.org/hgnc/3393"]},"label":"prostate cancer/brain cancer susceptibility","mondo":"MONDO:0011361","parents":["MONDO:0015356"],"predisposes_towards":{"mondo":["MONDO:0001657"]},"synonym":{"exact":["prostate cancer/brain cancer susceptibility","prostate cancer/brain cancer susceptibility, somatic"],"related":["Capb","Pcbc"]},"xrefs":{"medgen":["400334"],"omim":["603688"],"umls":["C1863600"]}}},{"_id":"MONDO:0018502","_score":7.36427,"mondo":{"ancestors":["MONDO:0005070","MONDO:0021223","MONDO:0700096","MONDO:0001056","MONDO:0004992","MONDO:0021085","MONDO:0005626","MONDO:0003847","MONDO:0004335","MONDO:0045024","MONDO:0002516","MONDO:0004950","MONDO:0004993","MONDO:0023370","MONDO:0004298","MONDO:0000001","MONDO:0006181"],"children":["MONDO:0006226","MONDO:0007648","MONDO:0017790","MONDO:0100256"],"definition":"Hereditary gastric cancer refers to the occurrence of gastric cancer in a familial context and is described as two or more cases of gastric cancer in first or second degree relatives with at least one case diagnosed before the age of 50. Familial clustering is observed in 10% of all cases of gastric cancer, and includes hereditary diffuse gastric cancer (early onset diffuse-type gastric cancer), gastric adenocarcinoma and proximal polyposis of the stomach and familial intestinal gastric cancer (familial clustering of intestinal type gastric adenocarcinoma). Hereditary gastric cancer can also occur in other hereditary cancer syndromes such as Lynch syndrome, Li-Fraumeni syndrome, familial adenomatous polyposis and juvenile polyposis syndrome. [Orphanet:423776]","descendants":["MONDO:0100256","MONDO:0017790","MONDO:0007648","MONDO:0006226"],"label":"hereditary gastric cancer","mondo":"MONDO:0018502","parents":["MONDO:0003847","MONDO:0004950"],"synonym":{"exact":["hereditary cancer of stomach","hereditary gastric cancer"]},"xrefs":{"gard":["21758"],"medgen":["1843054"],"orphanet":["423776"],"umls":["C5680075"]}}},{"_id":"MONDO:0001060","_score":7.269791,"disease_ontology":{"_license":"https://github.com/DiseaseOntology/HumanDiseaseOntology/blob/master/DO_LICENSE.txt","ancestors":["DOID:14566","DOID:5517","DOID:305","DOID:3119","DOID:0050686","DOID:10534","DOID:4","DOID:76","DOID:77","DOID:7","DOID:0050687","DOID:162","DOID:3717","DOID:299"],"children":[],"def":"","descendants":[],"doid":"DOID:10541","name":"microinvasive gastric cancer","parents":["DOID:3717"],"synonyms":{"exact":["early gastric cancer","Surface gastric cancer"]},"xrefs":{"ncit":"C27131","snomedct_us_2023_03_01":"276809004","umls_cui":"C0349530"}},"disgenet":{"_license":"https://creativecommons.org/licenses/by/4.0/","genes_related_to_disease":[{"DPI":0.885,"DSI":0.429,"EI":1.0,"YearFinal":2017,"YearInitial":2017,"gene_id":174,"gene_name":"AFP","pubmed":[29121872],"score":0.01,"source":"BEFREE"},{"DPI":0.962,"DSI":0.373,"EI":1.0,"YearFinal":2016,"YearInitial":2014,"gene_id":324,"gene_name":"APC","pubmed":[27514024,24272205],"score":0.02,"source":"BEFREE"},{"DPI":0.808,"DSI":0.502,"EI":1.0,"YearFinal":2017,"YearInitial":2017,"gene_id":387,"gene_name":"RHOA","pubmed":[28624843],"score":0.01,"source":"BEFREE"},{"DPI":0.923,"DSI":0.344,"EI":1.0,"YearFinal":2014,"YearInitial":2014,"gene_id":595,"gene_name":"CCND1","pubmed":[25202078],"score":0.01,"source":"BEFREE"},{"DPI":0.423,"DSI":0.666,"EI":1.0,"YearFinal":2017,"YearInitial":2017,"gene_id":618,"gene_name":"BCYRN1","pubmed":[29039538],"score":0.01,"source":"BEFREE"},{"DPI":0.731,"DSI":0.459,"EI":1.0,"YearFinal":2008,"YearInitial":2008,"gene_id":864,"gene_name":"RUNX3","pubmed":[18097595],"score":0.01,"source":"BEFREE"},{"DPI":0.962,"DSI":0.363,"EI":1.0,"YearFinal":2019,"YearInitial":2016,"gene_id":960,"gene_name":"CD44","pubmed":[27923017,30913874,25779358],"score":0.03,"source":"BEFREE"},{"DPI":0.808,"DSI":0.401,"EI":1.0,"YearFinal":2010,"YearInitial":2010,"gene_id":999,"gene_name":"CDH1","pubmed":[20063069],"score":0.01,"source":"BEFREE"},{"DPI":0.769,"DSI":0.458,"EI":1.0,"YearFinal":2019,"YearInitial":2019,"gene_id":1045,"gene_name":"CDX2","pubmed":[31354341],"score":0.01,"source":"BEFREE"},{"DPI":0.846,"DSI":0.42,"EI":1.0,"YearFinal":2018,"YearInitial":2017,"gene_id":1048,"gene_name":"CEACAM5","pubmed":[29121872,29742692],"score":0.02,"source":"BEFREE"},{"DPI":0.731,"DSI":0.494,"EI":1.0,"YearFinal":2018,"YearInitial":2017,"gene_id":1084,"gene_name":"CEACAM3","pubmed":[29121872,29742692],"score":0.02,"source":"BEFREE"},{"DPI":0.769,"DSI":0.494,"EI":1.0,"YearFinal":2018,"YearInitial":2017,"gene_id":1087,"gene_name":"CEACAM7","pubmed":[29121872,29742692],"score":0.02,"source":"BEFREE"},{"DPI":0.808,"DSI":0.446,"EI":1.0,"YearFinal":2017,"YearInitial":2017,"gene_id":1268,"gene_name":"CNR1","pubmed":[27271924],"score":0.01,"source":"BEFREE"},{"DPI":0.846,"DSI":0.4,"EI":1.0,"YearFinal":2018,"YearInitial":2018,"gene_id":1351,"gene_name":"COX8A","pubmed":[30128004],"score":0.01,"source":"BEFREE"},{"DPI":0.615,"DSI":0.558,"EI":1.0,"YearFinal":2012,"YearInitial":2012,"gene_id":1365,"gene_name":"CLDN3","pubmed":[22290341],"score":0.01,"source":"BEFREE"},{"DPI":0.808,"DSI":0.494,"EI":1.0,"YearFinal":2012,"YearInitial":2012,"gene_id":1366,"gene_name":"CLDN7","pubmed":[22290341],"score":0.01,"source":"BEFREE"},{"DPI":0.846,"DSI":0.488,"EI":1.0,"YearFinal":2018,"YearInitial":2018,"gene_id":1371,"gene_name":"CPOX","pubmed":[29425880],"score":0.01,"source":"BEFREE"},{"DPI":0.923,"DSI":0.328,"EI":1.0,"YearFinal":2005,"YearInitial":2005,"gene_id":1636,"gene_name":"ACE","pubmed":[16365022],"score":0.01,"source":"BEFREE"},{"DPI":0.885,"DSI":0.426,"EI":1.0,"YearFinal":2019,"YearInitial":2019,"gene_id":1666,"gene_name":"DECR1","pubmed":[31370714],"score":0.01,"source":"BEFREE"},{"DPI":0.885,"DSI":0.295,"EI":1.0,"YearFinal":2015,"YearInitial":2015,"gene_id":1956,"gene_name":"EGFR","pubmed":[25593477],"score":0.01,"source":"BEFREE"},{"DPI":0.923,"DSI":0.328,"EI":1.0,"YearFinal":2018,"YearInitial":2015,"gene_id":2064,"gene_name":"ERBB2","pubmed":[30120594,25593477],"score":0.02,"source":"BEFREE"},{"DPI":0.615,"DSI":0.656,"EI":1.0,"YearFinal":2019,"YearInitial":2017,"gene_id":2098,"gene_name":"ESD","pubmed":[31382963,30725253,28378078,30298447],"score":0.04,"source":"BEFREE"},{"DPI":0.692,"DSI":0.588,"EI":1.0,"YearFinal":2017,"YearInitial":2017,"gene_id":2168,"gene_name":"FABP1","pubmed":[27884752],"score":0.01,"source":"BEFREE"},{"DPI":0.846,"DSI":0.474,"EI":1.0,"YearFinal":2017,"YearInitial":2017,"gene_id":2194,"gene_name":"FASN","pubmed":[27884752],"score":0.01,"source":"BEFREE"},{"DPI":0.808,"DSI":0.485,"EI":1.0,"YearFinal":2017,"YearInitial":2017,"gene_id":2520,"gene_name":"GAST","pubmed":[28072871],"score":0.01,"source":"BEFREE"},{"DPI":0.808,"DSI":0.489,"EI":1.0,"YearFinal":2019,"YearInitial":2019,"gene_id":2744,"gene_name":"GLS","pubmed":[30485682],"score":0.01,"source":"BEFREE"},{"DPI":0.577,"DSI":0.686,"EI":1.0,"YearFinal":2017,"YearInitial":2017,"gene_id":3004,"gene_name":"GZMM","pubmed":[28977792],"score":0.01,"source":"BEFREE"},{"DPI":0.885,"DSI":0.374,"EI":1.0,"YearFinal":2017,"YearInitial":2017,"gene_id":3082,"gene_name":"HGF","pubmed":[28595915],"score":0.01,"source":"BEFREE"},{"DPI":0.769,"DSI":0.476,"EI":1.0,"YearFinal":2015,"YearInitial":2015,"gene_id":3490,"gene_name":"IGFBP7","pubmed":[26043748],"score":0.01,"source":"BEFREE"},{"DPI":0.923,"DSI":0.373,"EI":1.0,"YearFinal":2004,"YearInitial":2004,"gene_id":3557,"gene_name":"IL1RN","pubmed":[15570075],"score":0.01,"source":"BEFREE"},{"DPI":0.962,"DSI":0.248,"EI":1.0}]}}],"_note":"Response truncated for documentation purposes"}
curl --location --request GET 'https://zylalabs.com/api/4424/diseases+information+api/5437/disease?q=cancer' --header 'Authorization: Bearer YOUR_API_KEY'
इस एंडपॉइंट का उपयोग करने के लिए आपको पैरामीटर में एक मोंडो आईडी निर्दिष्ट करनी होगी
उदाहरण के लिए: MONDO:0011361
यह आईडी आपको रोग एंडपॉइंट से मिलेगी
{"_id":"MONDO:0011361","_version":1,"ctd":{"omim":"603688","pathway_related_to_disease":[{"inference_gene_symbol":"EPHB2","kegg_pathway_id":"hsa04360","pathway_name":"Axon guidance","source":"CTD"},{"inference_gene_symbol":"EPHB2","pathway_name":"Developmental Biology","react_pathway_id":"R-HSA-1266738","source":"CTD"},{"inference_gene_symbol":"EPHB2","pathway_name":"EPH-Ephrin signaling","react_pathway_id":"R-HSA-2682334","source":"CTD"},{"inference_gene_symbol":"EPHB2","pathway_name":"L1CAM interactions","react_pathway_id":"R-HSA-373760","source":"CTD"},{"inference_gene_symbol":"EPHB2","pathway_name":"EPHB-mediated forward signaling","react_pathway_id":"R-HSA-3928662","source":"CTD"},{"inference_gene_symbol":"EPHB2","pathway_name":"Ephrin signaling","react_pathway_id":"R-HSA-3928664","source":"CTD"},{"inference_gene_symbol":"EPHB2","pathway_name":"EPH-ephrin mediated repulsion of cells","react_pathway_id":"R-HSA-3928665","source":"CTD"},{"inference_gene_symbol":"EPHB2","pathway_name":"Axon guidance","react_pathway_id":"R-HSA-422475","source":"CTD"}]},"disgenet":{"_license":"https://creativecommons.org/licenses/by/4.0/","genes_related_to_disease":[{"DPI":0.846,"DSI":0.374,"gene_id":2048,"gene_name":"EPHB2","score":0.4,"source":"CLINVAR"},{"DPI":0.846,"DSI":0.374,"gene_id":2048,"gene_name":"EPHB2","score":0.4,"source":"CTD_human"}],"variants_related_to_disease":[{"DSI":1.0,"chrom":"1","pos":22907980,"rsid":"rs121912582","score":0.7,"source":"CLINVAR"},{"DPI":0.08,"DSI":0.882,"chrom":"1","pos":22913757,"rsid":"rs76826147","score":0.7,"source":"CLINVAR"}],"xrefs":{"disease_name":"PROSTATE CANCER/BRAIN CANCER SUSCEPTIBILITY (finding)","mondo":"MONDO:0011361","omim":"603688","umls":"C1863600"}},"hpo":{"disease_name":"Prostate cancer/brain cancer susceptibility","omim":"603688","phenotype_related_to_disease":[{"biocuration":{"date":"2013-01-14","name":"HPO:skoehler"},"evidence":"IEA","hpo_id":"HP:0100006","omim_refs":"OMIM:603688","original_disease_id":"OMIM:603688"},{"biocuration":{"date":"2013-01-09","name":"HPO:skoehler"},"evidence":"IEA","hpo_id":"HP:0012125","omim_refs":"OMIM:603688","original_disease_id":"OMIM:603688"}]},"mondo":{"ancestors":["MONDO:0003847","MONDO:0020573","MONDO:0023370","MONDO:0021058","MONDO:0700096","MONDO:0002254","MONDO:0045024","MONDO:0042489","MONDO:0015356","MONDO:0000001"],"excluded_subClassOf":{"mondo":["MONDO:0008315"]},"has_material_basis_in_germline_mutation_in":{"http":["http://identifiers.org/hgnc/3393"]},"label":"prostate cancer/brain cancer susceptibility","mondo":"MONDO:0011361","parents":["MONDO:0015356"],"predisposes_towards":{"mondo":["MONDO:0001657"]},"synonym":{"exact":["prostate cancer/brain cancer susceptibility","prostate cancer/brain cancer susceptibility, somatic"],"related":["Capb","Pcbc"]},"xrefs":{"medgen":["400334"],"omim":["603688"],"umls":["C1863600"]}}}
curl --location --request GET 'https://zylalabs.com/api/4424/diseases+information+api/5439/disease+by+id&ID=Required' --header 'Authorization: Bearer YOUR_API_KEY'
| हेडर | विवरण |
|---|---|
Authorization
|
[आवश्यक] होना चाहिए Bearer access_key. जब आप सब्सक्राइब हों तो ऊपर "Your API Access Key" देखें। |
कोई लंबी अवधि की प्रतिबद्धता नहीं। कभी भी अपग्रेड, डाउनग्रेड या कैंसल करें। फ्री ट्रायल में 50 रिक्वेस्ट तक शामिल हैं।
बीमारियों की जानकारी एपीआई विभिन्न बीमारियों पर संरचित डेटा और जानकारी प्रदान करता है जिसमें आनुवंशिक कारक, संबंधित जीन, नैदानिक अभिव्यक्तियाँ और संबंधित पथ शामिल हैं
Zyla लगभग सभी प्रोग्रामिंग भाषाओं के लिए एक विस्तृत श्रृंखला के एकीकरण विधियाँ प्रदान करता है आप अपनी जरूरत के अनुसार इन कोडों का उपयोग अपने प्रोजेक्ट के साथ एकीकृत करने के लिए कर सकते हैं
सभी पसंदों के लिए विभिन्न योजनाएँ हैं जिनमें कुछ अनुरोधों के लिए मुफ्त परीक्षण शामिल है लेकिन आपकी दर का उपयोग सेवाओं के दुरुपयोग से बचाने के लिए सीमित है
यह एपीआई आवश्यक है क्योंकि यह उपयोगकर्ताओं को विभिन्न बीमारियों के बारे में विस्तृत और अद्यतन जानकारी प्राप्त करने की अनुमति देती है जिसमें आनुवंशिक डेटा संबंधित जीन वेरिएंट क्लिनिकल डेटा और प्रासंगिक पाथवेज शामिल हैं
इस एपीआई का उपयोग करने के लिए, उपयोगकर्ताओं को एक बीमारी का नाम बताना होगा
GET रोग अंत बिंदु संबंधित जीन, आनुवंशिक परिवर्तनों और नैदानिक प्रकाशनों के साथ रोगों की सूची लौटाता है GET रोग द्वारा आईडी अंत बिंदु एक विशिष्ट बीमारी के बारे में विस्तृत जानकारी प्रदान करता है जिसमें बीमारी से संबंधित पथ और जीन इंटरैक्शन शामिल हैं
मुख्य क्षेत्रों में "_id" (रोग पहचानकर्ता), "ctd" (जीन और मार्गों से संबंधित डेटा), "omim" (ऑनलाइन मैंडेलियन हेरिटेज इन मैन आईडी), और "pathway_related_to_disease" (रोग से जुड़े मार्गों की सूची) शामिल हैं
प्रतिक्रिया डेटा JSON प्रारूप में संरचित है जिसमें एक शीर्ष स्तर का वस्तु मेटाडेटा (जैसे "लिया" और "कुल") और "हिट्स" का एक सरणी है जो प्रत्येक बीमारी की जानकारी का विवरण देती है जिसमें संबंधित जीन और मार्ग शामिल होते हैं
GET रोग अंतर्गामी रोगों के नाम, संबंधित जीन और आनुवंशिकी भिन्नताओं प्रदान करता है GET रोग आईडी द्वारा अंतर्गामी एक विशेष रोग के बारे में गहन विवरण, जिसमें मार्ग, जीन अंतःक्रियाएँ और नैदानिक डेटा शामिल है
GET Disease एंडपॉइंट एक पैरामीटर के रूप में बीमारी का नाम मांगता है जबकि GET Disease by ID एंडपॉइंट एक विशिष्ट मोंडो आईडी की मांग करता है ये पैरामीटर उपयोगकर्ताओं को लक्षित जानकारी के लिए अपने क्वेरी को अनुकूलित करने की अनुमति देते हैं
उपयोगकर्ता लौटाए गए डेटा का विश्लेषण कर सकते हैं ताकि बीमारियों से जुड़े आनुवंशिक कारकों की पहचान की जा सके clínica निर्णय लेने में सहायता करें और बीमारियों के तंत्र पर शोध की जानकारी दें संरचित प्रारूप अनुप्रयोगों में सहज एकीकरण की अनुमति देता है
यह डेटा प्रतिष्ठित जैव चिकित्सा डेटाबेस से लिया गया है जिसमें तुलनात्मक विषाक्त जीनोमिक्स डेटाबेस (CTD) और ऑनलाइन मेनडेलियन विरासत इन मैन (OMIM) शामिल हैं जो उच्च सटीकता और विश्वसनीयता सुनिश्चित करते हैं
अगर एपीआई आंशिक या खाली परिणाम लौटाता है तो उपयोगकर्ताओं को इनपुट पैरामीटर की सटीकता की जांच करनी चाहिए इसके अलावा परिणाम पुनर्प्राप्ति में सुधार करने के लिए व्यापक खोज शर्तों का उपयोग करने या वैकल्पिक रोग नामों की जांच करने पर विचार करें
सर्विस लेवल:
100%
रिस्पॉन्स टाइम:
293ms
सर्विस लेवल:
100%
रिस्पॉन्स टाइम:
221ms
सर्विस लेवल:
100%
रिस्पॉन्स टाइम:
330ms
सर्विस लेवल:
100%
रिस्पॉन्स टाइम:
224ms
सर्विस लेवल:
100%
रिस्पॉन्स टाइम:
620ms
सर्विस लेवल:
100%
रिस्पॉन्स टाइम:
1,083ms
सर्विस लेवल:
100%
रिस्पॉन्स टाइम:
160ms
सर्विस लेवल:
100%
रिस्पॉन्स टाइम:
3,504ms
सर्विस लेवल:
100%
रिस्पॉन्स टाइम:
196ms
सर्विस लेवल:
100%
रिस्पॉन्स टाइम:
250ms